Lilly rises on CVS Zepbound addition
Eli Lilly stock gains after CVS adds Zepbound to its drug list, potentially increasing demand. This move may boost Lilly's sales.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.